Literature DB >> 11296621

Determinants of place of death for terminal cancer patients.

S T Tang1, R McCorkle.   

Abstract

Approximately two-third of cancer patients, when asked about the preferred place of death, wish to die in their own homes. However, the majority of deaths from cancers in most western countries occur in a hospital. When a person dies from other than sudden or traumatic causes, the death appears to be a function of a complex interplay of personal and cultural values and physical and medical factors, as well as various health care systems forces. This article reviews the determinants of place of death for terminal cancer patients from published studies in hopes of shedding light on the difficulties of dying patients to realize their preferences for place of death. These insights may contribute to modification of hospice care systems so health professionals will be more responsive to the needs of their dying patients to retain control and die with dignity and help health professionals achieve the proposed outcome of hospice care.

Entities:  

Mesh:

Year:  2001        PMID: 11296621     DOI: 10.1081/cnv-100000151

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  33 in total

1.  Predictors of home care expenditures and death at home for cancer patients in an integrated comprehensive palliative home care pilot program.

Authors:  Doris M Howell; Tom Abernathy; Rhonda Cockerill; Kevin Brazil; Frank Wagner; Larry Librach
Journal:  Healthc Policy       Date:  2011-02

2.  Communication on end-of-life decisions with patients wishing to die at home: the making of a guideline for GPs in Flanders, Belgium.

Authors:  Reginald Deschepper; Robert Vander Stichele; Jan L Bernheim; Els De Keyser; Greta Van Der Kelen; Freddy Mortier; Luc Deliens
Journal:  Br J Gen Pract       Date:  2006-01       Impact factor: 5.386

Review 3.  Factors influencing death at home in terminally ill patients with cancer: systematic review.

Authors:  Barbara Gomes; Irene J Higginson
Journal:  BMJ       Date:  2006-02-08

4.  Which hospice patients with cancer are able to die in the setting of their choice? Results of a retrospective cohort study.

Authors:  Neha Jeurkar; Sue Farrington; Teresa R Craig; Julie Slattery; Joan K Harrold; Betty Oldanie; Joan M Teno; David J Casarett
Journal:  J Clin Oncol       Date:  2012-06-25       Impact factor: 44.544

5.  Where a cancer patient dies: the effect of rural residency.

Authors:  Frederick Burge; Beverley Lawson; Grace Johnston
Journal:  J Rural Health       Date:  2005       Impact factor: 4.333

6.  Factors associated with place of death for elderly Japanese-American men: the Honolulu Heart Program and Honolulu-Asia Aging Study.

Authors:  Christina L Bell; James Davis; Rosanne C Harrigan; Emese Somogyi-Zalud; Marianne K G Tanabe; Kamal H Masaki
Journal:  J Am Geriatr Soc       Date:  2009-01-21       Impact factor: 5.562

7.  Association of hospice patients' income and care level with place of death.

Authors:  Joshua S Barclay; Maragatha Kuchibhatla; James A Tulsky; Kimberly S Johnson
Journal:  JAMA Intern Med       Date:  2013-03-25       Impact factor: 21.873

8.  What's the Plan? Needing Assistance with Plan of Care Is Associated with In-Hospital Death for ICU Patients Referred for Palliative Care Consultation.

Authors:  Ayano Kiyota; Christina L Bell; Kamal Masaki; Daniel J Fischberg
Journal:  Hawaii J Med Public Health       Date:  2016-08

9.  Patterns of care at end of life for people with primary intracranial tumors: lessons learned.

Authors:  Abdulrahman Alturki; Bruno Gagnon; Kevin Petrecca; Susan C Scott; Lyne Nadeau; Nancy Mayo
Journal:  J Neurooncol       Date:  2014-01-28       Impact factor: 4.130

10.  Principles and Recommendations for the Provision of Healthcare in Canada to Adolescent and Young Adult-Aged Cancer Patients and Survivors.

Authors:  Conrad Fernandez; Graeme A M Fraser; Carolyn Freeman; Eva Grunfeld; Abha Gupta; Leslie Stephen Mery; Sonja De Pauw; Brent Schacter
Journal:  J Adolesc Young Adult Oncol       Date:  2011-04       Impact factor: 2.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.